Pyrrolidine

Pyrrolidine

SCHEMBL7079209

C1CCNC1.Cc1ccccc1[N+](=O)[O-]

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.71
TSHR P16473 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
TDP1 Q9NUW8 5/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
NPC1 O15118 2/20 0.43
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 4/20 0.42
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
CYP3A4 P08684 1/20 0.41
RECQL P46063 1/20 0.41
HPGD P15428 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Morpholine SCHEMBL7074183 0.85 HSD17B10 (0.65) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
SCHEMBL29859415 0.84 HSD17B10 (1.00) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
SCHEMBL26788 0.84 HSD17B10 (1.00) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
SCHEMBL8044782 0.82 HSD17B10 (0.95) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
SCHEMBL11125458 0.82 HSD17B10 (0.95) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
SCHEMBL27660568 0.82 HSD17B10 (0.95) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
SCHEMBL29289466 0.82 HSD17B10 (0.95) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
SCHEMBL8044778 0.82 HSD17B10 (0.95) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
Ammonia Solution, Strong SCHEMBL9579917 0.82 HSD17B10 (0.95) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1
Bromide SCHEMBL28560244 0.82 HSD17B10 (0.95) HSD17B10TSHRSMN1; SMN2TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003504-B1 INDOLE DERIVATIVES AND THEIR USE AS MCP-1 ANTAGONISTS ASTRAZENECA AB (SE) 2003-07-02 EP disclosed